Breast, Ovarian, and Lung Cancer: Screening, Diagnosis, and Personalized Management in 2014
MiRNAs and biomarkers Gabriella Sozzi. diagnostic microRNAs in lung tumors stratifying lung cancer molecular subtypes ( Landi L. et al) prognostic.
J Thorac Dis 2013;5(S5) Estimated 10 year survival 88%, regardless of treatment Survival rate 92% if surgical resection in 1 month.
Kentucky Cancer Consortium Resource Plan July 2013.
© 2015 American College of Physicians The information contained herein should never be used as a substitute for clinical judgment.
1 The U.S. Preventive Services Task Force: The Challenge of Transparency Dr. Albert Siu New York Academy of Medicine.
MicroRNA and lung cancer Gabriella Sozzi. Lung Cancer Screening by LDCT : critical issues Recent clinical trials results (DANTE, 2009, DLCST, 2012, MILD.
Patient is a man, 60 years, smoker (60 p/y), who has lost one of his friend two week ago because of progressive lung cancer. He is worried about his.
May 28 – 30, 2015, Montréal, Québec A Canadian Approach to Lung Cancer Screening: What every radiologist should know.
miRNAs and biomarkers
Thoracic Oncology Preprint Ch07